A small UK biotech developing a neuro-oncology-specific therapy was preparing for an IND submission, and required extra support with their non-clinical documents (CTD modules 2.4 and 2.6). 

The critical role of medical writing for regulatory interactions, nonclinical IND sections and preparing for clinical trials The path...